Literature DB >> 27959741

Von Willebrand's Disease.

Frank W G Leebeek1, Jeroen C J Eikenboom1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27959741     DOI: 10.1056/NEJMra1601561

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  115 in total

1.  Intra-Abdominal Pseudotumors: A Rare Presentation of Von Willebrand Disease and its Management in Resource Constraint Setting.

Authors:  Kunwer Abhishek Ary; Veenu Singla; Kundan Mishra; Aditya Jandial; Rajeev Sandal; Deepesh Lad; Gaurav Prakash; Alka Khadwal; Jasmina Ahluwalia; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-12       Impact factor: 0.900

2.  Diagnosis and management of patients with von Willebrand's disease in Italy: an Expert Meeting Report.

Authors:  Flora Peyvandi
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

3.  Von Willebrand factor deficiency reduces liver fibrosis in mice.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; Holly Cline-Fedewa; Dafna J Groeneveld; Ton Lisman; James P Luyendyk
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-17       Impact factor: 4.219

4.  Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Margaret V Ragni
Journal:  Blood Adv       Date:  2017-04-25

5.  Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defects.

Authors:  Seema Nandi; Laura Sommerville; Kimberly Nellenbach; Emily Mihalko; Mary Erb; Donald O Freytes; Maureane Hoffman; Dougald Monroe; Ashley C Brown
Journal:  J Colloid Interface Sci       Date:  2020-05-26       Impact factor: 8.128

6.  Blood type association with bleeding outcomes at delivery in a large multi-center study.

Authors:  Najeebah A Bade; Jamil M Kazma; Richard L Amdur; Julia Ellis-Kahana; Homa K Ahmadzia
Journal:  J Thromb Thrombolysis       Date:  2020-08       Impact factor: 2.300

7.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

Authors:  Nathan T Connell; Veronica H Flood; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Alice Arapshian; Susie Couper; Jean M Grow; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Sarah H O'Brien; Margareth C Ozelo; Alberto Tosetto; Angela C Weyand; Paula D James; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

8.  Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease.

Authors:  Laura H Bukkems; Jessica M Heijdra; Nico C B de Jager; Hendrika C A M Hazendonk; Karin Fijnvandraat; Karina Meijer; Jeroen C J Eikenboom; Britta A P Laros-van Gorkom; Frank W G Leebeek; Marjon H Cnossen; Ron A A Mathôt
Journal:  Blood Adv       Date:  2021-03-09

9.  Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management.

Authors:  F W G Leebeek; R Muslem
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 10.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.